🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareWeekly check-in thread — March 10–16, 2026 Page 2

Weekly check-in thread — March 10–16, 2026

mike_mod Sun, May 31, 2026 at 8:46 PM 7 replies 337 viewsPage 2 of 2
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jun 1, 2026 at 2:50 AM#6
Dr.ObesityMed said:
Relative and absolute effects need reading together.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

Last edited: Jun 1, 2026 at 3:50 AM
37 7maya_sedona, stefan_berlin, Dr.EM_Chicago and 34 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jun 1, 2026 at 5:13 AM#7
mike_mod said:
I keep finding that the number in the press summary and the number in the paper are not the same number, and the difference is always in the same…
mike_mod said:
...regarding the trial evidence...

I think this is an underappreciated point. To expand on it with some data:

A recent meta-analysis of 15 RCTs (n=12,300) found that the trial evidence was associated with a clinically meaningful effect size across diverse patient populations[1].

The NNT was 12, which is comparable to antihypertensives for stroke reduction. That's a strong clinical argument for this approach.

Last edited: Jun 1, 2026 at 10:13 AM
36 6stefan_berlin, Dr.EM_Chicago, pete_RVA and 33 others
Reply Quote Save Share Report
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
Jun 1, 2026 at 7:36 AM#8
BethLabQueen said:
I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them.

Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to:

  1. Point estimate (HR/RR/OR) — center of the diamond
  2. Confidence interval width — precision of the estimate
  3. I² statistic — heterogeneity across studies
  4. Individual study weights — are results driven by one large trial?
  5. Prediction interval — range of plausible true effects in future settings

The the trial evidence meta-analysis shows a pooled RR of 0.86 (95% CI 0.70-0.91), I²=59%. This is a robust and consistent effect.

Last edited: Jun 1, 2026 at 11:36 AM
35 5Dr.ReproEndo, lucas_SP_BR, lisa_labSD and 32 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SurmountFan_IN
Member
789
3,456
May 2024
Indianapolis, IN
Jun 1, 2026 at 9:59 AM#9

Following on from LipidDoc_ATL — and this may be the naive question:

How long did you give it before you decided it was working?

34 4rachel_ABQ, traveltech_sara, AttorneyGrant and 31 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jun 1, 2026 at 9:24 PM#10

OP back with an update, since a thread like this is useless without one.

Follow-up: I read the paper rather than the summary and the qualifier I was missing was in the second paragraph of the results.

28 3PurityPaulOR, MaxMetOK, MounjBrad and 25 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register